Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (54 quarters reported)
$141M in Q2 2013 → $766M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Uipath Inc | 54.5% | Added 5.0% | 32,500,000 | $417M |
| Kolibri Global Energy Inc | 5.5% | Unchanged | 6,834,504 | $42.3M |
| Silence Therapeutics PLC | 3.5% | Added 219% | 2,436,051 | $26.6M |
| PN Pharvaris Nv | 3.5% | Added 184% | 838,247 | $26.6M |
| Ionis Pharmaceuticals Inc | 2.6% | Added 354% | 440,930 | $19.7M |
| Autolus Therapeutics Ltd | 2.4% | Unchanged | 9,500,000 | $18.4M |
| AP Arrowhead Pharmaceuticals In | 2.3% | Added 102% | 264,040 | $17.3M |
| Lyft Inc | 2.0% | Unchanged | 1,000,000 | $15M |
| Workiva Inc | 2.0% | Trimmed 10% | 225,000 | $15M |
| Mbx Biosciences Inc | 1.7% | Added 8.4% | 220,647 | $12.9M |
| Definium Therapeutics Inc | 1.5% | Added 8.3% | 310,892 | $11.8M |
| Sprinklr Inc | 1.4% | Unchanged | 2,200,000 | $10.9M |
| CT Celldex Therapeutics Inc New | 1.3% | Added 1.9% | 295,941 | $9.59M |
| Immunovant Inc | 1.2% | Added 7.5% | 275,219 | $9.3M |
| HB Harmony Biosciences Hldgs In | 1.2% | Added 13% | 226,677 | $8.9M |
| Alkami Technology Inc | 1.2% | Added 8.3% | 650,000 | $8.9M |
| Alkermes PLC | 1.1% | Added 8.8% | 206,778 | $8.38M |
| Dyne Therapeutics Inc | 1.1% | Added 43% | 511,280 | $8.24M |
| Relay Therapeutics Inc | 1.1% | Trimmed 22% | 447,235 | $8.07M |
| Agios Pharmaceuticals Inc | 0.9% | Added 4.8% | 215,529 | $7.17M |
| Celcuity Inc | 0.9% | Added 36% | 87,421 | $6.95M |
| Neurocrine Biosciences Inc | 0.9% | New | 47,014 | $6.67M |
| Krystal Biotech Inc | 0.9% | Unchanged | 19,668 | $6.54M |
| Axsome Therapeutics Inc. | 0.8% | New | 35,000 | $6.45M |
| Warner Bros Discovery Inc | 0.8% | Trimmed 20% | 200,000 | $6.19M |
| Nektar Therapeutics | 0.8% | Added 17% | 101,645 | $6.15M |
| Silence Therapeutics PLC Call | 0.7% | Added 67% | 500,000 | $5.47M |
| Uber Technologies Inc | 0.6% | New | 71,428 | $4.89M |
| Snowflake Inc | 0.4% | Unchanged | 10,000 | $3.4M |
| An2 Therapeutics Inc | 0.4% | New | 603,424 | $3.21M |
| Annexon Inc | 0.4% | Trimmed 47% | 655,948 | $2.77M |
| Agios Pharmaceuticals Inc Call | 0.2% | Unchanged | 50,000 | $1.66M |
| Monte Rosa Therapeutics Inc Call | 0.2% | New | 100,000 | $1.19M |
| Monte Rosa Therapeutics Inc | 0.1% | Unchanged | 56,052 | $669K |
| Tectonic Therapeutic Inc | 0.1% | Trimmed 42% | 26,798 | $624K |
| Sol-gel Technologies Ltd | 0.1% | New | 8,307 | $617K |
| Tenax Therapeutics Inc Call | 0.0% | Unchanged | 75,100 | $142K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 16, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Uipath Inc | Added | +1,550,000 | +$19.9M | 54.5% |
| Silence Therapeutics PLC | Added | +1,671,795 | +$18.3M | 3.5% |
| PN Pharvaris Nv | Added | +542,620 | +$17.2M | 3.5% |
| Ionis Pharmaceuticals Inc | Added | +343,757 | +$15.3M | 2.6% |
| AP Arrowhead Pharmaceuticals In | Added | +133,556 | +$8.74M | 2.3% |
| Axsome Therapeutics Inc. | Exited | −35,000 | −$8.57M | — |
| Neurocrine Biosciences Inc | New | +47,014 | +$6.67M | 0.9% |
| Axsome Therapeutics Inc. | New | +35,000 | +$6.45M | 0.8% |
| Amylyx Pharmaceuticals Inc | Exited | −297,926 | −$5.35M | — |
| Uber Technologies Inc | New | +71,428 | +$4.89M | 0.6% |
Showing the 10 largest of 36 changes.
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Uipath Inc | Added | +5,742,372 | +$62.4M | 53.0% |
| Warner Bros Discovery Inc | Trimmed | −673,725 | −$18M | 1.0% |
| Alkami Technology Inc | New | +600,284 | +$10.9M | 1.7% |
| Relay Therapeutics Inc | Added | +388,768 | +$7.27M | 1.7% |
| Celcuity Inc | New | +64,110 | +$6.71M | 1.1% |
| PP Praxis Precision Medicines I | Exited | −15,952 | −$5.14M | — |
| Ionis Pharmaceuticals Inc | Added | +55,409 | +$4.39M | 1.2% |
| Definium Therapeutics Inc | Added | +86,996 | +$4.09M | 2.1% |
| Soleno Therapeutics Inc | Exited | −102,125 | −$3.42M | — |
| Axsome Therapeutics Inc. | Exited | −20,059 | −$3.39M | — |
Showing the 10 largest of 38 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Uipath Inc | Added | +7,757,628 | +$86.1M | 54.3% |
| Warner Bros Discovery Inc | New | +923,725 | +$25.4M | 4.9% |
| Workiva Inc | Added | +100,000 | +$5.96M | 2.9% |
| Axsome Therapeutics Inc. | New | +35,000 | +$5.92M | 1.1% |
| Rapt Therapeutics Inc | Exited | −131,770 | −$4.46M | — |
| Annexon Inc | Trimmed | −740,000 | −$4.1M | 1.4% |
| Definium Therapeutics Inc | New | +199,994 | +$3.78M | 0.7% |
| Amicus Therapeutics Inc | Exited | −260,771 | −$3.71M | — |
| Soleno Therapeutics Inc | New | +102,125 | +$3.42M | 0.7% |
| Acadia Pharmaceuticals Inc | New | +144,620 | +$3.22M | 0.6% |
Showing the 10 largest of 36 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AG Alibaba Group Hldg Ltd | Exited | −95,000,000 | −$175M | — |
| IT Ishares Tr | Exited | −726,900 | −$59M | — |
| Lithium Argentina Ag | Exited | −27,109,000 | −$24.6M | — |
| Cable One Inc | Exited | −21,255,000 | −$20.8M | — |
| Progress Software Corp | Exited | −20,500,000 | −$20.6M | — |
| Oatly Group Ab | Exited | −20,020,027 | −$18.4M | — |
| Uipath Inc | Added | +500,000 | +$8.2M | 60.3% |
| First Majestic Silver Corp | Exited | −7,500,000 | −$7.97M | — |
| Celcuity Inc | Exited | −5,550,000 | −$7.44M | — |
| Tarsus Pharmaceuticals Inc | Exited | −125,000 | −$7.43M | — |
Showing the 10 largest of 47 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Uipath Inc | Added | +3,227,756 | +$43.2M | 30.3% |
| Jd.com Inc | Exited | −20,000,000 | −$20.9M | — |
| Cable One Inc | New | +21,255,000 | +$20.8M | 2.8% |
| Progress Software Corp | New | +20,500,000 | +$20.6M | 2.8% |
| Trip Com Group Ltd | Exited | −10,000,000 | −$11.1M | — |
| Lithium Argentina Ag | Added | +10,500,000 | +$9.51M | 3.3% |
| AG Alibaba Group Hldg Ltd | Trimmed | −5,000,000 | −$9.2M | 23.4% |
| IT Ishares Tr | Trimmed | −95,100 | −$7.72M | 7.9% |
| Celcuity Inc | New | +5,550,000 | +$7.44M | 1.0% |
| Tarsus Pharmaceuticals Inc | Trimmed | −125,000 | −$7.43M | 1.0% |
Showing the 10 largest of 41 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AG Alibaba Group Hldg Ltd | New | +100,000,000 | +$128M | 20.6% |
| IT Ishares Tr | Trimmed | −779,900 | −$62.9M | 10.7% |
| Uipath Inc | Added | +4,772,244 | +$61.1M | 28.3% |
| Jd.com Inc | New | +20,000,000 | +$20.9M | 3.4% |
| Informatica Inc | Exited | −800,000 | −$14M | — |
| Trip Com Group Ltd | New | +10,000,000 | +$11.1M | 1.8% |
| Workiva Inc | New | +150,000 | +$10.3M | 1.7% |
| First Majestic Silver Corp | Trimmed | −9,000,000 | −$8.74M | 1.2% |
| Lithium Argentina Ag | Trimmed | −6,700,000 | −$5.68M | 2.3% |
| SM Ssr Mining In | Exited | −4,000,000 | −$4.08M | — |
Showing the 10 largest of 34 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Added | +610,100 | +$48.1M | 28.8% |
| Uipath Inc | Added | +2,000,000 | +$20.6M | 21.0% |
| SM Ssr Mining In | Trimmed | −16,000,000 | −$16.3M | 0.9% |
| BA Bigbear Ai Hldgs Inc | Exited | −900,000 | −$4.01M | — |
| MP Medical Pptys Trust Inc | Exited | −902,500 | −$3.56M | — |
| Informatica Inc | Added | +200,000 | +$3.49M | 3.2% |
| Tectonic Therapeutic Inc | New | +187,500 | +$3.32M | 0.8% |
| Annexon Inc | Added | +1,250,000 | +$2.41M | 1.2% |
| Immunovant Inc | New | +131,167 | +$2.24M | 0.5% |
| IT Ishares Tr | Trimmed | −27,185 | −$2.14M | 1.1% |
Showing the 10 largest of 26 changes.
quarter ended December 31, 2024 · filed February 21, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Added | +531,800 | +$41.8M | 19.9% |
| Tarsus Pharmaceuticals Inc | Trimmed | −414,117 | −$22.9M | 2.8% |
| First Majestic Silver Corp | Trimmed | −22,920,000 | −$20.8M | 3.6% |
| Informatica Inc | Added | +200,000 | +$5.19M | 4.0% |
| CT Celldex Therapeutics Inc New | New | +192,000 | +$4.85M | 1.2% |
| Ballys Corporation | Exited | −278,493 | −$4.8M | — |
| BA Bigbear Ai Hldgs Inc | New | +900,000 | +$4.01M | 1.0% |
| Axsome Therapeutics Inc | New | +41,250 | +$3.49M | 0.9% |
| Oatly Group Ab | Added | +4,645,432 | +$3.44M | 3.6% |
| Annexon Inc | Added | +615,645 | +$3.16M | 1.8% |
Showing the 10 largest of 20 changes.
Loading...